Skip to main content
PTGX $140.06 +0.63%
PTGX logo
PTGX · Protagonist Therapeutics, Inc
Track PTGX — free
$140.06 +0.87 (+0.63%) At close · Oct 2
Market Cap
$9.18B
Shares
64.71M
Volume · Oct 2 760.3K Avg daily vol (3M) 634.39K
All webcasts

Earnings call · FY2024 Q4

Protagonist Therapeutics, Inc (PTGX) Q4 2024 Earnings Call

Concluded Feb 21, 2025
Feb 21, 2025 0 turns
Period
FY2024 Q4
Runtime
—
Sources
2 artifacts

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $170.64M +184.4% YoY
Net income · derived Q4 $131.67M +381.7% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document